,Set,NGenes,Direction,PValue,FDR
1,WP_SMALL_LIGAND_GPCRS,7,Down,7.18121652245311e-06,0.00590295998145646
2,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,4.01042128495671e-05,0.0122434655873942
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,5.35844634248772e-05,0.0122434655873942
4,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,5.95789079678549e-05,0.0122434655873942
5,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.000176335325505321,0.026722606275174
6,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,56,Down,0.000224440926618154,0.026722606275174
7,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Down,0.000227564773632868,0.026722606275174
8,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.000651932143984495,0.0669860277944068
9,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.000802189930987479,0.073266680363523
10,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.00130334005784713,0.0909093400177598
11,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.0014630712838302,0.0909093400177598
12,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.00150621333410339,0.0909093400177598
13,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.00154641808414322,0.0909093400177598
14,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.00154833425821002,0.0909093400177598
15,WP_EBOLA_VIRUS_INFECTION_IN_HOST,106,Down,0.00215321802106346,0.117996347554277
16,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,20,Down,0.00275708532855488,0.141645258754507
17,WP_PEPTIDE_GPCRS,15,Down,0.00343998706787779,0.166333492340914
18,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Up,0.00433871371589075,0.198134593025678
19,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.00533043298957091,0.212746681696491
20,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.005398058064084,0.212746681696491
21,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.00543513420392494,0.212746681696491
22,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.00782920067005815,0.292527406853991
23,WP_MEVALONATE_PATHWAY,7,Down,0.00847350901115771,0.301730149790841
24,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.00880963940995155,0.301730149790841
25,WP_CREATINE_PATHWAY,2,Up,0.0102145160251362,0.331761496021729
26,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0107513540627742,0.331761496021729
27,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.0113000582704028,0.331761496021729
28,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.0114218992257055,0.331761496021729
29,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.0117044810031997,0.331761496021729
30,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.0128490024703567,0.352062667687772
31,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,30,Down,0.0138146283174005,0.366310466996877
32,WP_OSTEOBLAST_SIGNALING,3,Down,0.0144251107664409,0.370545032812951
33,WP_NRXN1_DELETION_SYNDROME,2,Up,0.0151274334770478,0.376810615701009
34,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.0161362083085199,0.390116565576568
35,WP_CHOLESTEROL_METABOLISM,52,Down,0.0188173718784318,0.438652269311648
36,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.0194868119731662,0.438652269311648
37,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,52,Down,0.0197446885213272,0.438652269311648
38,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.0214568615796824,0.462374487587258
39,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.0225740435322758,0.462374487587258
40,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.0229399553860702,0.462374487587258
41,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0230624744417002,0.462374487587258
42,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,31,Down,0.024299402627727,0.475574022856943
43,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.0249455807975123,0.476866684082677
44,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0263819252804737,0.492862331376122
45,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.0273533358656147,0.499654268478561
46,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.0299053580326632,0.519752996919847
47,WP_DISORDERS_IN_KETOLYSIS,3,Down,0.0300149104409129,0.519752996919847
48,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.0303896816248134,0.519752996919847
49,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0311997102794278,0.519752996919847
50,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.0316151457980442,0.519752996919847
51,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.0343004436155523,0.532458447729993
52,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.0343824948717459,0.532458447729993
53,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.0347138844284426,0.532458447729993
54,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.0354049092688673,0.532458447729993
55,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.0356267817824204,0.532458447729993
56,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.0363473702641763,0.533527470663445
57,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0374276503947711,0.539698528817595
58,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.0380809180917525,0.539698528817595
59,WP_TAMOXIFEN_METABOLISM,2,Up,0.0408784356011246,0.569526679052957
60,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.043349287257202,0.593885235423668
61,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.044150466822384,0.594945634885239
62,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.0452216828539442,0.599551988805518
63,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.0473027376839542,0.612140908803822
64,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.0476606060382538,0.612140908803822
65,WP_BENZENE_METABOLISM,3,Down,0.0492078016676165,0.617751079514295
66,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Down,0.0496004516398339,0.617751079514295
67,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.0516149172793163,0.621979927533854
68,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.0519359878262522,0.621979927533854
69,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.0522099939170753,0.621979927533854
70,WP_IL10_ANTIINFLAMMATORY_SIGNALING,12,Down,0.0537775400825702,0.629071958150057
71,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.0543358990616229,0.629071958150057
72,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0574234796515163,0.654529446074839
73,WP_MEASLES_VIRUS_INFECTION,102,Down,0.0581273109044565,0.654529446074839
74,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.0617951150067821,0.654984415006727
75,WP_CANCER_PATHWAYS,308,Down,0.0618440728408728,0.654984415006727
76,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,41,Down,0.0621319628643131,0.654984415006727
77,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.0627659447286775,0.654984415006727
78,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.0630978205714496,0.654984415006727
79,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Up,0.0632734380132681,0.654984415006727
80,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.0646632720088246,0.654984415006727
81,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,23,Down,0.0657480771494706,0.654984415006727
82,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.06575233316912,0.654984415006727
83,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.0668127085071249,0.654984415006727
84,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.0686715078173511,0.654984415006727
85,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.0689065477424864,0.654984415006727
86,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,21,Down,0.0691917113921797,0.654984415006727
87,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Up,0.0693231680116609,0.654984415006727
88,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,37,Up,0.0705506288875663,0.659007010745221
89,WP_IL7_SIGNALING,23,Down,0.0732897079106209,0.672309291203064
90,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.0742438672662145,0.672309291203064
91,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.0744284008509475,0.672309291203064
92,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.0761131356630936,0.675776604635611
93,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,59,Up,0.0770450909565371,0.675776604635611
94,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.0779113263385318,0.675776604635611
95,WP_RETINOL_METABOLISM,6,Down,0.0781007024822178,0.675776604635611
96,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.0809964785765763,0.68461793253323
97,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Up,0.0813911702209694,0.68461793253323
98,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.0819207788115418,0.68461793253323
99,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.0842769370848582,0.68461793253323
100,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.085066444391113,0.68461793253323
101,WP_GLUTATHIONE_METABOLISM,10,Down,0.0854967968783317,0.68461793253323
102,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.0858897625862333,0.68461793253323
103,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.0863997724942393,0.68461793253323
104,WP_VEGFAVEGFR2_SIGNALING,341,Down,0.0868027448814442,0.68461793253323
105,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.0881623905243898,0.68461793253323
106,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.0885854997878818,0.68461793253323
107,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.0891242657053381,0.68461793253323
108,WP_IDO_METABOLIC_PATHWAY,8,Up,0.0900144069260894,0.68461793253323
109,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.0924875497043199,0.68461793253323
110,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.0929726906184287,0.68461793253323
111,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.0931230847234671,0.68461793253323
112,WP_NEPHROGENESIS,4,Up,0.0937405378457291,0.68461793253323
113,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0942554548192546,0.68461793253323
114,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.0949470125411048,0.68461793253323
115,WP_NEURAL_CREST_DIFFERENTIATION,40,Down,0.097000969180791,0.693346057970523
116,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.0982740990624356,0.69371884654767
117,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.100737642135057,0.69371884654767
118,WP_CHEMOKINE_SIGNALING,109,Down,0.101608243121558,0.69371884654767
119,WP_RETINOBLASTOMA_GENE_IN_CANCER,71,Down,0.10219706439577,0.69371884654767
120,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.104896499512801,0.69371884654767
121,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.104931620473993,0.69371884654767
122,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.106230690579379,0.69371884654767
123,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.106994653716196,0.69371884654767
124,WP_GLUCURONIDATION,7,Down,0.110537069657758,0.69371884654767
125,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,2,Down,0.110699455067737,0.69371884654767
126,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.112328278589308,0.69371884654767
127,WP_NOTCH_SIGNALING_WP268,36,Down,0.112357963154262,0.69371884654767
128,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,11,Down,0.112699425140274,0.69371884654767
129,WP_KCNQ2RELATED_EPILEPSIES,12,Up,0.112765982921669,0.69371884654767
130,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.112867115659206,0.69371884654767
131,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.113764125135691,0.69371884654767
132,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.114886445618778,0.69371884654767
133,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.114951975235157,0.69371884654767
134,WP_ACUTE_VIRAL_MYOCARDITIS,67,Down,0.116921899487075,0.69371884654767
135,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.117276518047544,0.69371884654767
136,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Up,0.117337289597019,0.69371884654767
137,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.117825948585555,0.69371884654767
138,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.119421923127956,0.69371884654767
139,WP_IL9_SIGNALING,15,Down,0.120495498167165,0.69371884654767
140,WP_DOPAMINE_METABOLISM,7,Down,0.120894514476447,0.69371884654767
141,WP_MACROPHAGE_MARKERS,9,Up,0.121227029915331,0.69371884654767
142,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.121646398749051,0.69371884654767
143,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.122506715880571,0.69371884654767
144,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Down,0.123661085868784,0.69371884654767
145,WP_15Q25_COPY_NUMBER_VARIATION,27,Up,0.125297436339649,0.69371884654767
146,WP_REGULATION_OF_ACTIN_CYTOSKELETON,89,Down,0.125399477215566,0.69371884654767
147,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.1260893392145,0.69371884654767
148,WP_SPHINGOLIPID_PATHWAY,21,Down,0.126518659840953,0.69371884654767
149,WP_PDGF_PATHWAY,36,Down,0.12855296994807,0.69371884654767
150,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.12903825253604,0.69371884654767
151,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.129417690688093,0.69371884654767
152,WP_RAS_SIGNALING,116,Down,0.129789569325637,0.69371884654767
153,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.131341509427841,0.69371884654767
154,WP_NRF2_PATHWAY,73,Down,0.131893442941632,0.69371884654767
155,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Down,0.132183790304369,0.69371884654767
156,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.133385661306759,0.69371884654767
157,WP_PURINE_METABOLISM,10,Up,0.13398258039587,0.69371884654767
158,WP_CHOLESTASIS,9,Down,0.134158239578756,0.69371884654767
159,WP_ENDOTHELIN_PATHWAYS,13,Down,0.13447298203661,0.69371884654767
160,WP_MAPK_SIGNALING,163,Down,0.135457914069369,0.69371884654767
161,WP_FOCAL_ADHESION,118,Down,0.135874372620651,0.69371884654767
162,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.139633944208676,0.706379962112437
163,WP_GPCRS_CLASS_A_RHODOPSINLIKE,44,Down,0.140072912195045,0.706379962112437
164,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Down,0.144110942322518,0.722312162128717
165,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.145834553041041,0.726521227877188
166,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.147213691384978,0.728973821195491
167,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.149633753998586,0.735231841035463
168,WP_BREAST_CANCER_PATHWAY,87,Down,0.150266361671482,0.735231841035463
169,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.152172422950862,0.739739597592188
170,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,72,Down,0.153740311712899,0.739739597592188
171,WP_PRION_DISEASE_PATHWAY,28,Down,0.154540818679266,0.739739597592188
172,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.156200144115695,0.739739597592188
173,WP_NAD_METABOLISM,12,Down,0.156206584166856,0.739739597592188
174,WP_RAC1PAK1P38MMP2_PATHWAY,50,Down,0.156848144859504,0.739739597592188
175,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.163634241844091,0.739739597592188
176,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.164211485499255,0.739739597592188
177,WP_MONOAMINE_GPCRS,3,Down,0.164654527909904,0.739739597592188
178,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.165708994922959,0.739739597592188
179,WP_AGERAGE_PATHWAY,54,Down,0.165769761592557,0.739739597592188
180,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.165901077017118,0.739739597592188
181,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.166336693508857,0.739739597592188
182,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.16655893612434,0.739739597592188
183,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Up,0.167076898804519,0.739739597592188
184,WP_G13_SIGNALING,29,Down,0.167270863086212,0.739739597592188
185,WP_IL19_SIGNALING,20,Down,0.16794412249539,0.739739597592188
186,WP_IRINOTECAN_PATHWAY,5,Up,0.168047537124926,0.739739597592188
187,WP_GPR40_PATHWAY,8,Up,0.171188777764557,0.739739597592188
188,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.171602898059392,0.739739597592188
189,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.172533828816013,0.739739597592188
190,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.172773709502115,0.739739597592188
191,WP_TGFB_SMAD_SIGNALING,8,Down,0.173497658375175,0.739739597592188
192,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.174197994324499,0.739739597592188
193,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.174517399181883,0.739739597592188
194,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.174585744443898,0.739739597592188
195,WP_SMALL_CELL_LUNG_CANCER,71,Down,0.177520023534259,0.748315176129031
196,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.178449395174613,0.748394912415978
197,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,8,Up,0.180016368955838,0.751134290770043
198,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.182032139315468,0.752393660194419
199,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.182148830144391,0.752393660194419
200,WP_FERROPTOSIS,51,Down,0.183650852684884,0.752848688345058
201,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,13,Down,0.184090737661018,0.752848688345058
202,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.187502626035407,0.763005735649034
203,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.189395774245096,0.766912938076201
204,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,12,Up,0.19051090689367,0.767646889542139
205,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.192406659925441,0.769878315267056
206,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.196005765118511,0.769878315267056
207,WP_TP53_NETWORK,16,Up,0.196012127389918,0.769878315267056
208,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.196355110794853,0.769878315267056
209,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,66,Down,0.196998834816564,0.769878315267056
210,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.197394094552535,0.769878315267056
211,WP_PROSTAGLANDIN_SIGNALING,23,Down,0.198597546734295,0.769878315267056
212,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.199689057043847,0.769878315267056
213,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.200011741419473,0.769878315267056
214,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.200997498339822,0.769878315267056
215,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,10,Up,0.201367199248682,0.769878315267056
216,WP_KININKALLIKREIN_PATHWAY,2,Down,0.206384459357795,0.774444920651488
217,WP_IL5_SIGNALING,37,Down,0.207191918657237,0.774444920651488
218,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Down,0.208315777055987,0.774444920651488
219,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.208820079600563,0.774444920651488
220,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.210715061102671,0.774444920651488
221,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.212302991663001,0.774444920651488
222,WP_HEPATITIS_B_INFECTION,116,Down,0.213885994096113,0.774444920651488
223,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.214809541840129,0.774444920651488
224,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.214847781677361,0.774444920651488
225,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.21492706588287,0.774444920651488
226,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,17,Down,0.216911198766544,0.774444920651488
227,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Up,0.218287434707554,0.774444920651488
228,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,58,Down,0.221107935435261,0.774444920651488
229,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.222116911309695,0.774444920651488
230,WP_PROTEASOME_DEGRADATION,57,Down,0.224098217660046,0.774444920651488
231,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.224399929214769,0.774444920651488
232,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.225131347211879,0.774444920651488
233,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.225735223273972,0.774444920651488
234,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.226985461657012,0.774444920651488
235,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.227565723047297,0.774444920651488
236,WP_MELANOMA,54,Down,0.228006426528546,0.774444920651488
237,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,2,Down,0.228398770844745,0.774444920651488
238,WP_NEPHROTIC_SYNDROME,28,Down,0.230634459915455,0.774444920651488
239,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.23091301060039,0.774444920651488
240,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.231993820908779,0.774444920651488
241,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.23353971479599,0.774444920651488
242,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.235726606370575,0.774444920651488
243,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.236981898479559,0.774444920651488
244,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.237284915331491,0.774444920651488
245,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.237665044623807,0.774444920651488
246,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.238825310685955,0.774444920651488
247,WP_ALZHEIMERS_DISEASE,184,Down,0.238900325352181,0.774444920651488
248,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.238900325352181,0.774444920651488
249,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.239746144535765,0.774444920651488
250,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.240109735492501,0.774444920651488
251,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.240826365593708,0.774444920651488
252,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.24095750184518,0.774444920651488
253,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,96,Down,0.241576229680766,0.774444920651488
254,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.242341533233217,0.774444920651488
255,WP_ZINC_HOMEOSTASIS,24,Down,0.243875320941374,0.774444920651488
256,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.245861324077702,0.774444920651488
257,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.248204573672426,0.774444920651488
258,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.248209872232326,0.774444920651488
259,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.248971242605783,0.774444920651488
260,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.249107395974818,0.774444920651488
261,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.249275359726415,0.774444920651488
262,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,142,Down,0.249633083810966,0.774444920651488
263,WP_ASPIRIN_AND_MIRNAS,8,Up,0.250803107624953,0.774444920651488
264,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.251120033518422,0.774444920651488
265,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.251469561378502,0.774444920651488
266,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.252377672170659,0.774444920651488
267,WP_BENZOAPYRENE_METABOLISM,5,Up,0.253019764571304,0.774444920651488
268,WP_COPPER_HOMEOSTASIS,40,Down,0.253429436626013,0.774444920651488
269,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Up,0.253830401038702,0.774444920651488
270,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.254379718462168,0.774444920651488
271,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.260063014005064,0.784824857991777
272,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.261261915191595,0.784824857991777
273,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.261608285997259,0.784824857991777
274,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.261608285997259,0.784824857991777
275,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.263592067550511,0.785099359395064
276,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Up,0.264395413963435,0.785099359395064
277,WP_COMPLEMENT_ACTIVATION,13,Up,0.2645651125942,0.785099359395064
278,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Up,0.267053908856997,0.789634219713854
279,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.26923218171139,0.793221696655063
280,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.270846710598282,0.793836835862915
281,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.273512373473448,0.793836835862915
282,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.273550300322626,0.793836835862915
283,WP_NUCLEAR_RECEPTORS_METAPATHWAY,179,Down,0.274298324302553,0.793836835862915
284,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Down,0.276212837676318,0.793836835862915
285,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.277242854467351,0.793836835862915
286,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.277464701916579,0.793836835862915
287,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Up,0.277481416708786,0.793836835862915
288,WP_MTHFR_DEFICIENCY,18,Up,0.279030503245163,0.793836835862915
289,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,78,Down,0.28023883861217,0.793836835862915
290,WP_ENDOMETRIAL_CANCER,48,Down,0.281148801656748,0.793836835862915
291,WP_PDGFRBETA_PATHWAY,27,Down,0.281197808415188,0.793836835862915
292,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.281995566997532,0.793836835862915
293,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Up,0.283061049461208,0.794116664358746
294,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.287554212198457,0.803978103493644
295,WP_METABOLIC_EPILEPTIC_DISORDERS,56,Up,0.289460071012211,0.806563316515381
296,WP_IL2_SIGNALING,37,Down,0.291108114040479,0.807581282753645
297,WP_NOTCH_SIGNALING_WP61,49,Down,0.292362618867082,0.807581282753645
298,WP_SPINAL_CORD_INJURY,67,Down,0.292775462653732,0.807581282753645
299,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Down,0.293755235454185,0.807581282753645
300,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.294999159342145,0.808297696597478
301,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Down,0.296190262450406,0.808626264246987
302,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.297086535039647,0.808626264246987
303,WP_AXON_GUIDANCE,37,Down,0.300594025670042,0.815472901322689
304,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.302841219864808,0.81886671950287
305,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,40,Down,0.304463287564751,0.820293369974372
306,WP_CCL18_SIGNALING,21,Down,0.310651558273765,0.820293369974372
307,WP_NUCLEAR_RECEPTORS,20,Up,0.313230111507963,0.820293369974372
308,WP_PURINERGIC_SIGNALING,14,Down,0.314501051859862,0.820293369974372
309,WP_ENDOCHONDRAL_OSSIFICATION,27,Down,0.314923339371104,0.820293369974372
310,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Down,0.314923339371104,0.820293369974372
311,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.316097276330667,0.820293369974372
312,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,16,Up,0.316357735760803,0.820293369974372
313,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Down,0.318217468831094,0.820293369974372
314,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.318272738430825,0.820293369974372
315,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Up,0.318274398899493,0.820293369974372
316,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.319065813083564,0.820293369974372
317,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.31993113315015,0.820293369974372
318,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.320361140656105,0.820293369974372
319,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.320361140656105,0.820293369974372
320,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.32113810209134,0.820293369974372
321,WP_KREBS_CYCLE_DISORDERS,11,Down,0.322073647242366,0.820293369974372
322,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.322201427580421,0.820293369974372
323,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.322844436568386,0.820293369974372
324,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.325283175048982,0.820293369974372
325,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,19,Up,0.32565390040698,0.820293369974372
326,WP_COMPLEMENT_SYSTEM,52,Up,0.326155949793925,0.820293369974372
327,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.326922161663192,0.820293369974372
328,WP_P38_MAPK_SIGNALING,31,Down,0.327490749658684,0.820293369974372
329,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.3283169327513,0.820293369974372
330,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.332406260593888,0.820775287804253
331,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.332473422053029,0.820775287804253
332,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Up,0.332695563697015,0.820775287804253
333,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Down,0.333426953149279,0.820775287804253
334,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.333502367550633,0.820775287804253
335,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Down,0.336649555936544,0.825251393382532
336,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.339871858949948,0.825251393382532
337,WP_OPIOID_RECEPTOR_PATHWAYS,26,Down,0.343945716724112,0.825251393382532
338,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.344901176204045,0.825251393382532
339,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.34545030610258,0.825251393382532
340,WP_GPCRS_OTHER,14,Up,0.345707948246487,0.825251393382532
341,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.346641168221952,0.825251393382532
342,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.347178742499042,0.825251393382532
343,WP_TLR4_SIGNALING_AND_TOLERANCE,27,Down,0.348280745705763,0.825251393382532
344,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.349794012480898,0.825251393382532
345,WP_GASTRIN_SIGNALING,92,Down,0.351124395997231,0.825251393382532
346,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.351607353815137,0.825251393382532
347,WP_MALE_INFERTILITY,69,Up,0.352661303199754,0.825251393382532
348,WP_TAR_SYNDROME,44,Down,0.352998877653492,0.825251393382532
349,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Up,0.355279120699317,0.825251393382532
350,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Up,0.35575132575044,0.825251393382532
351,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.356019304166592,0.825251393382532
352,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.356742044157729,0.825251393382532
353,WP_MIRNA_BIOGENESIS,6,Down,0.356875212854099,0.825251393382532
354,WP_CAMKK2_PATHWAY,29,Down,0.357440313493727,0.825251393382532
355,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Up,0.357550566814384,0.825251393382532
356,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.35851393306208,0.825251393382532
357,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.359950928596139,0.825251393382532
358,WP_GALANIN_RECEPTOR_PATHWAY,12,Up,0.360031562630764,0.825251393382532
359,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.360420012438356,0.825251393382532
360,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.364371985648818,0.830818964109628
361,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.365964001950357,0.830818964109628
362,WP_BLOOD_CLOTTING_CASCADE,7,Down,0.366760252214204,0.830818964109628
363,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.366894506048412,0.830818964109628
364,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.368411531029339,0.831962303588233
365,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.371780422429361,0.83722645177517
366,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.375453504351247,0.83722645177517
367,WP_THERMOGENESIS,73,Down,0.376059381011595,0.83722645177517
368,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.376665640863974,0.83722645177517
369,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.377008871567679,0.83722645177517
370,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.377564328298272,0.83722645177517
371,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.377872279329182,0.83722645177517
372,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.379979983681663,0.83748755618216
373,WP_NONSMALL_CELL_LUNG_CANCER,59,Down,0.380027808340566,0.83748755618216
374,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.384330337682273,0.840943319853022
375,WP_VITAMIN_B12_METABOLISM,27,Up,0.386750736361048,0.840943319853022
376,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.387197578590682,0.840943319853022
377,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.388163015482726,0.840943319853022
378,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,7,Up,0.38823874089322,0.840943319853022
379,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.388304289072232,0.840943319853022
380,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.391496859647497,0.840943319853022
381,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Down,0.391581956919214,0.840943319853022
382,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,13,Down,0.391595721520306,0.840943319853022
383,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.392570049248941,0.840943319853022
384,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.392849434091923,0.840943319853022
385,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.398587004796862,0.851009137514339
386,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.401330448900014,0.854646707243036
387,WP_KIT_RECEPTOR_SIGNALING,51,Up,0.405167309558832,0.860587928830386
388,WP_MATRIX_METALLOPROTEINASES,8,Up,0.408711814463394,0.863782293981338
389,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.40910314189241,0.863782293981338
390,WP_MRNA_PROCESSING,124,Up,0.409823716122533,0.863782293981338
391,WP_HEART_DEVELOPMENT,16,Down,0.4122056690135,0.864630435276513
392,WP_PLEURAL_MESOTHELIOMA,257,Down,0.412329842613617,0.864630435276513
393,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.417019464485268,0.871232939161394
394,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.417598270108989,0.871232939161394
395,WP_BURN_WOUND_HEALING,60,Up,0.419438903032237,0.872857666563289
396,WP_TRANSSULFURATION_PATHWAY,8,Up,0.421605530217093,0.875134762494171
397,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.422662409623097,0.875134762494171
398,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.426079575205571,0.876430473791746
399,WP_CYTOSOLIC_DNASENSING_PATHWAY,54,Down,0.428835441684188,0.876430473791746
400,WP_IRON_METABOLISM_DISORDERS,13,Down,0.429155218381539,0.876430473791746
401,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.430454940828465,0.876430473791746
402,WP_KALLMANN_SYNDROME,11,Down,0.432215360491407,0.876430473791746
403,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,30,Up,0.432419840273234,0.876430473791746
404,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.43398615248431,0.876430473791746
405,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.433992182176916,0.876430473791746
406,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.434905032879201,0.876430473791746
407,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.435309167542954,0.876430473791746
408,WP_TRYPTOPHAN_METABOLISM,19,Down,0.436793033213966,0.876430473791746
409,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.439289285414006,0.876430473791746
410,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,21,Up,0.441183672523438,0.876430473791746
411,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.441274813222715,0.876430473791746
412,WP_CELLULAR_PROTEOSTASIS,6,Up,0.441644543090174,0.876430473791746
413,WP_KLEEFSTRA_SYNDROME,25,Up,0.441854704224596,0.876430473791746
414,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Up,0.44259338508674,0.876430473791746
415,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.443123209231567,0.876430473791746
416,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.443546322502879,0.876430473791746
417,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.4462480299824,0.879654390037249
418,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,9,Down,0.447984717133077,0.880965161443516
419,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.451292753773215,0.885352371364159
420,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.456771812653609,0.889356753934669
421,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.45693727865022,0.889356753934669
422,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,31,Down,0.458076101837046,0.889356753934669
423,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,33,Down,0.459928173266795,0.889356753934669
424,WP_CELL_CYCLE,95,Down,0.460114796812596,0.889356753934669
425,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Down,0.462088445875095,0.889356753934669
426,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.462166008601333,0.889356753934669
427,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.462203547992805,0.889356753934669
428,WP_OREXIN_RECEPTOR_PATHWAY,120,Up,0.464101645935023,0.889356753934669
429,WP_POSTCOVID_NEUROINFLAMMATION,13,Down,0.464153342381962,0.889356753934669
430,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,79,Down,0.465546312415557,0.889395024698831
431,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.466337293972258,0.889395024698831
432,WP_FOXA2_PATHWAY,9,Up,0.467665425276546,0.889863378651205
433,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Down,0.469500056614314,0.890875863550672
434,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.470365115305343,0.890875863550672
435,WP_EGFEGFR_SIGNALING,138,Down,0.47456364876925,0.894518328382578
436,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.475427092974238,0.894518328382578
437,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.477017533658532,0.894518328382578
438,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.477670464918964,0.894518328382578
439,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.477729374890452,0.894518328382578
440,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Down,0.47896699115896,0.89479742439242
441,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.488991857575744,0.90631956119263
442,WP_DNA_DAMAGE_RESPONSE,59,Down,0.489365821611982,0.90631956119263
443,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.48941609854913,0.90631956119263
444,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.489544872469012,0.90631956119263
445,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Up,0.491385301288764,0.907682511594077
446,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,36,Up,0.495163527571945,0.912431496755694
447,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.49717833101639,0.912431496755694
448,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.497552282848035,0.912431496755694
449,WP_ENERGY_METABOLISM,41,Down,0.499109685105363,0.912431496755694
450,WP_NPHP1_DELETION_SYNDROME,10,Down,0.501396425153108,0.912431496755694
451,WP_ANGIOGENESIS,14,Up,0.501477194761473,0.912431496755694
452,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.501726321816999,0.912431496755694
453,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Down,0.503553906552636,0.913389695896727
454,WP_MAPK_CASCADE,30,Down,0.504475574132742,0.913389695896727
455,WP_SPINA_BIFIDA,10,Up,0.507854985010075,0.917487467424794
456,WP_TYPE_II_DIABETES_MELLITUS,14,Up,0.511478436331163,0.918636377331774
457,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.512090862286121,0.918636377331774
458,WP_B_CELL_RECEPTOR_SIGNALING,85,Up,0.512700572362019,0.918636377331774
459,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.512961188802049,0.918636377331774
460,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.515134250983949,0.920522509366969
461,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.517107788234247,0.921934284926001
462,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,10,Up,0.519041245210768,0.921934284926001
463,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.519289019368295,0.921934284926001
464,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.524009898512194,0.923100983217674
465,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.524216721452462,0.923100983217674
466,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.525764774412728,0.923100983217674
467,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.525903854204214,0.923100983217674
468,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Up,0.526141588208642,0.923100983217674
469,WP_NEUROINFLAMMATION,10,Down,0.526684137626629,0.923100983217674
470,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Down,0.527919625582583,0.92329772814656
471,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.532726132163139,0.923867713609797
472,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.535048392964403,0.923867713609797
473,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.538387782471534,0.923867713609797
474,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Down,0.538656661897731,0.923867713609797
475,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.542607426123079,0.923867713609797
476,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.543730209982399,0.923867713609797
477,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.543811026909261,0.923867713609797
478,WP_HISTONE_MODIFICATIONS,37,Up,0.549611193141681,0.923867713609797
479,WP_TNFALPHA_SIGNALING,85,Down,0.550058779302047,0.923867713609797
480,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.551827258736203,0.923867713609797
481,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Down,0.552629414410104,0.923867713609797
482,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Down,0.555392711254286,0.923867713609797
483,WP_COMPLEMENT_AND_COAGULATION_CASCADES,27,Down,0.556049480188904,0.923867713609797
484,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,27,Down,0.556049480188904,0.923867713609797
485,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.556060130613277,0.923867713609797
486,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.556545633678196,0.923867713609797
487,WP_METHYLATION_PATHWAYS,5,Down,0.557544084451725,0.923867713609797
488,WP_HIPPO_SIGNALING_REGULATION,45,Down,0.557976094625174,0.923867713609797
489,WP_SERINE_METABOLISM,5,Up,0.558453292597984,0.923867713609797
490,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.561407994739691,0.923867713609797
491,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.561524169637593,0.923867713609797
492,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.563729660914054,0.923867713609797
493,WP_G_PROTEIN_SIGNALING,61,Down,0.564951642355224,0.923867713609797
494,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.565280453538433,0.923867713609797
495,WP_AEROBIC_GLYCOLYSIS,10,Up,0.565414419545018,0.923867713609797
496,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.565414419545018,0.923867713609797
497,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,29,Up,0.565827924816025,0.923867713609797
498,WP_ATR_SIGNALING,10,Down,0.566191573099563,0.923867713609797
499,WP_IL4_SIGNALING,50,Up,0.566481082320375,0.923867713609797
500,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.567678483567339,0.923867713609797
501,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Down,0.568739209482717,0.923867713609797
502,WP_NUCLEOTIDE_GPCRS,5,Up,0.569014887889855,0.923867713609797
503,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.569315382783056,0.923867713609797
504,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.569588456936251,0.923867713609797
505,WP_PRIMARY_OVARIAN_INSUFFICIENCY,91,Down,0.570612415857982,0.923867713609797
506,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,31,Up,0.57115027317652,0.923867713609797
507,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.572126615454775,0.923867713609797
508,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Down,0.574638102406138,0.923867713609797
509,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.575425721366166,0.923867713609797
510,WP_OSTEOPONTIN_SIGNALING,11,Down,0.575688255087828,0.923867713609797
511,WP_INTEGRATED_CANCER_PATHWAY,40,Down,0.576373467713502,0.923867713609797
512,WP_SILDENAFIL_TREATMENT,11,Up,0.577128439826859,0.923867713609797
513,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Down,0.57915750235102,0.923867713609797
514,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Down,0.57943578449362,0.923867713609797
515,WP_15Q11Q13_COPY_NUMBER_VARIATION,31,Down,0.580210260738072,0.923867713609797
516,WP_DNA_MISMATCH_REPAIR,21,Up,0.580370443521551,0.923867713609797
517,WP_ECTODERM_DIFFERENTIATION,77,Up,0.581070082647524,0.923867713609797
518,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.584792309072385,0.927990884280889
519,WP_PI3KAKT_SIGNALING,180,Down,0.586621832403788,0.929100474442993
520,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,172,Up,0.588432647667716,0.929704739705849
521,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.58929726852531,0.929704739705849
522,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.591802928252629,0.929704739705849
523,WP_CILIARY_LANDSCAPE,184,Down,0.592374602433229,0.929704739705849
524,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Down,0.593183718052948,0.929704739705849
525,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.593789523534758,0.929704739705849
526,WP_STEROID_BIOSYNTHESIS,2,Up,0.595908038493992,0.931247923273882
527,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.599134774910262,0.931505683254595
528,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Up,0.601432488043673,0.931505683254595
529,WP_PYRIMIDINE_METABOLISM,71,Up,0.60164689651455,0.931505683254595
530,WP_IL26_SIGNALING,33,Down,0.605176273877154,0.931505683254595
531,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.606375645540675,0.931505683254595
532,WP_GLYOXYLATE_METABOLISM,5,Down,0.606696846696652,0.931505683254595
533,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.607017802705585,0.931505683254595
534,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.608145516160506,0.931505683254595
535,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.609390337072288,0.931505683254595
536,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.611420440090248,0.931505683254595
537,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.612288545112313,0.931505683254595
538,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Up,0.613245136245704,0.931505683254595
539,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Down,0.614315392004781,0.931505683254595
540,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.614869239240075,0.931505683254595
541,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Up,0.615069129600873,0.931505683254595
542,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,272,Down,0.616958264494429,0.931505683254595
543,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,22,Down,0.619142219804304,0.931505683254595
544,WP_BASE_EXCISION_REPAIR,29,Down,0.621844507007614,0.931505683254595
545,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.622329409565023,0.931505683254595
546,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.623600135119615,0.931505683254595
547,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.623777050736295,0.931505683254595
548,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.624845107736218,0.931505683254595
549,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.625451147997554,0.931505683254595
550,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.625748708146852,0.931505683254595
551,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,51,Down,0.626198877905028,0.931505683254595
552,WP_BARDETBIEDL_SYNDROME,65,Up,0.626405348214956,0.931505683254595
553,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,14,Up,0.627310194136779,0.931505683254595
554,WP_WNT_SIGNALING_WP428,60,Down,0.628373988383392,0.931505683254595
555,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.630440062428585,0.931505683254595
556,WP_NETRINUNC5B_SIGNALING,36,Down,0.630855176113824,0.931505683254595
557,WP_ID_SIGNALING,12,Down,0.632557219772478,0.931505683254595
558,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.635379194681444,0.931505683254595
559,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.635379194681444,0.931505683254595
560,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.638060317732627,0.931505683254595
561,WP_LEPTIN_SIGNALING,69,Down,0.638604991648801,0.931505683254595
562,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,10,Down,0.638855811759276,0.931505683254595
563,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Up,0.638901053768432,0.931505683254595
564,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,127,Down,0.64016877694303,0.931505683254595
565,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.641730698091045,0.931505683254595
566,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.641876555859278,0.931505683254595
567,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.643436127158944,0.931505683254595
568,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Down,0.645478235139108,0.931505683254595
569,WP_TRANSLATION_FACTORS,49,Down,0.647439702305562,0.931505683254595
570,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Up,0.648018868213382,0.931505683254595
571,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Down,0.64818005005227,0.931505683254595
572,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.649520739007317,0.931505683254595
573,WP_ARYLAMINE_METABOLISM,1,Down,0.65026037173234,0.931505683254595
574,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.650467472248342,0.931505683254595
575,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.651761042504066,0.931734916414508
576,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.655433281082533,0.933508010188203
577,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.656239911860353,0.933508010188203
578,WP_HIPPOYAP_SIGNALING,16,Down,0.656927104456356,0.933508010188203
579,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.658501661409922,0.933508010188203
580,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.658679617894353,0.933508010188203
581,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.661596592849115,0.935597485817832
582,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.66243033667394,0.935597485817832
583,WP_LUNG_FIBROSIS,34,Down,0.665591639317784,0.937929453756496
584,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Up,0.66686263236287,0.937929453756496
585,WP_OVARIAN_INFERTILITY,21,Down,0.66750453825736,0.937929453756496
586,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.669016045313601,0.93844912840918
587,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.671661579285442,0.940555056512152
588,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.6754278129456,0.943262210872607
589,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.678238289894836,0.943262210872607
590,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.679476448843,0.943262210872607
591,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Up,0.680268929065815,0.943262210872607
592,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.683202404565816,0.943262210872607
593,WP_WNT_SIGNALING_WP363,38,Down,0.685669871894683,0.943262210872607
594,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Down,0.685787577978428,0.943262210872607
595,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.689167152028029,0.943262210872607
596,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.690085883223783,0.943262210872607
597,WP_HEME_BIOSYNTHESIS,8,Up,0.690085883223783,0.943262210872607
598,WP_INSULIN_SIGNALING,129,Up,0.690383301877305,0.943262210872607
599,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.690518827264065,0.943262210872607
600,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.691768175105956,0.943262210872607
601,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.692251645795366,0.943262210872607
602,WP_VITAMIN_D_METABOLISM,6,Down,0.694035990285609,0.943262210872607
603,WP_OSTEOCLAST_SIGNALING,9,Down,0.696854790908778,0.943262210872607
604,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.696964809130545,0.943262210872607
605,WP_PROLACTIN_SIGNALING,69,Up,0.698056596589528,0.943262210872607
606,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.698359576103549,0.943262210872607
607,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.69920081513274,0.943262210872607
608,WP_IL3_SIGNALING,46,Down,0.699582425517941,0.943262210872607
609,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.701499520233104,0.943262210872607
610,WP_JOUBERT_SYNDROME,70,Down,0.701703018293548,0.943262210872607
611,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.702202279837834,0.943262210872607
612,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,16,Up,0.702697450574827,0.943262210872607
613,WP_FOLATE_METABOLISM,40,Up,0.704466746352372,0.943262210872607
614,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.7074490604856,0.943262210872607
615,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.707638989514496,0.943262210872607
616,WP_IL6_SIGNALING,40,Down,0.708089362289791,0.943262210872607
617,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.708420336491463,0.943262210872607
618,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.711264182660873,0.943262210872607
619,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,48,Down,0.712132275241428,0.943262210872607
620,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.713474546439636,0.943262210872607
621,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.713911060554283,0.943262210872607
622,WP_FRAGILE_X_SYNDROME,83,Down,0.716488903109212,0.943262210872607
623,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.717526192547719,0.943262210872607
624,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.718313638079576,0.943262210872607
625,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.719110734897684,0.943262210872607
626,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Down,0.720696848869963,0.943262210872607
627,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.721488930525413,0.943262210872607
628,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.722951900783484,0.943262210872607
629,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.723280980888523,0.943262210872607
630,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.724278739964649,0.943262210872607
631,WP_HYPERTROPHY_MODEL,14,Up,0.724861305383132,0.943262210872607
632,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.725759771990322,0.943262210872607
633,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.72907038858339,0.943262210872607
634,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.733008925126955,0.943262210872607
635,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.733436289592337,0.943262210872607
636,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.73506524533818,0.943262210872607
637,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.736205410594012,0.943262210872607
638,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.736303281773525,0.943262210872607
639,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Up,0.736661880822955,0.943262210872607
640,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.737157713498008,0.943262210872607
641,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.737365374851797,0.943262210872607
642,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.739104598943566,0.943262210872607
643,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.739565334437157,0.943262210872607
644,WP_CYTOSINE_METHYLATION,7,Down,0.739584524110075,0.943262210872607
645,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.74015100488179,0.943262210872607
646,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.743814260335265,0.9436195112469
647,WP_RETT_SYNDROME,30,Down,0.745153626422762,0.9436195112469
648,WP_ESTROGEN_SIGNALING,21,Down,0.745383841163181,0.9436195112469
649,WP_SEROTONIN_AND_ANXIETY,6,Down,0.74753043806104,0.9436195112469
650,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.749262588932785,0.9436195112469
651,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.750587130976693,0.9436195112469
652,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.752607613467438,0.9436195112469
653,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.75366541396775,0.9436195112469
654,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Down,0.754127615267328,0.9436195112469
655,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.754791287357703,0.9436195112469
656,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.755404390847133,0.9436195112469
657,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.756460587525674,0.9436195112469
658,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.75727437895099,0.9436195112469
659,WP_BDNFTRKB_SIGNALING,26,Down,0.757507251466407,0.9436195112469
660,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.758428809748038,0.9436195112469
661,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,40,Down,0.758798658070804,0.9436195112469
662,WP_VITAMIN_B12_DISORDERS,9,Up,0.765237743069278,0.949479627869894
663,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Down,0.766047838186019,0.949479627869894
664,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.766976244410717,0.949479627869894
665,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,8,Up,0.769558356821731,0.949986558374948
666,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.770335774071255,0.949986558374948
667,WP_ADIPOGENESIS,87,Down,0.770852839946582,0.949986558374948
668,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Down,0.773605085326715,0.951951167872095
669,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Down,0.775389462170621,0.952492198252834
670,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.777509756480357,0.952492198252834
671,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.777767858495684,0.952492198252834
672,WP_IL17_SIGNALING,25,Up,0.778679753316185,0.952492198252834
673,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.791504677995609,0.962392400477344
674,WP_HUNGER_AND_SATIETY,2,Down,0.793284900242183,0.962392400477344
675,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,22,Up,0.793400597681297,0.962392400477344
676,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.79486113158565,0.962392400477344
677,WP_PPARALPHA_PATHWAY,15,Down,0.795029361021762,0.962392400477344
678,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.796249015886571,0.962392400477344
679,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.796419100916499,0.962392400477344
680,WP_CORI_CYCLE,11,Up,0.796534578865947,0.962392400477344
681,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.797310492366267,0.962392400477344
682,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.800684840176148,0.963862497739947
683,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.800873583888545,0.963862497739947
684,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.804343299553264,0.964299286721873
685,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Up,0.805229402048189,0.964299286721873
686,WP_IL11_SIGNALING,40,Down,0.80615487313008,0.964299286721873
687,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.808098527494768,0.964299286721873
688,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.808493708903777,0.964299286721873
689,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Down,0.809875357869546,0.964299286721873
690,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.81194651973486,0.964299286721873
691,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.813458642494153,0.964299286721873
692,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.813828604410911,0.964299286721873
693,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.814504000797373,0.964299286721873
694,WP_ALSTROM_SYNDROME,27,Down,0.814807417345389,0.964299286721873
695,WP_IL1_SIGNALING,53,Down,0.815605945932956,0.964299286721873
696,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,68,Up,0.818342936141865,0.964299286721873
697,WP_OXIDATIVE_DAMAGE_RESPONSE,35,Up,0.818813175621317,0.964299286721873
698,WP_APOPTOSIS,72,Up,0.818833214272344,0.964299286721873
699,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Up,0.825923710279248,0.969257632915414
700,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.826165341017888,0.969257632915414
701,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.826581022717403,0.969257632915414
702,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.828611743912723,0.970254777060197
703,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.834005057629729,0.973971553168421
704,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.834319424954119,0.973971553168421
705,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.835340565673646,0.973971553168421
706,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.838730276192769,0.97581155033832
707,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.840053764310357,0.97581155033832
708,WP_DNA_REPLICATION,35,Down,0.841499162524134,0.97581155033832
709,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.842388095993595,0.97581155033832
710,WP_ALLOGRAFT_REJECTION,52,Down,0.842854258808038,0.97581155033832
711,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.844824340525246,0.976274220621224
712,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,19,Up,0.846836319351538,0.976274220621224
713,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.847542739191885,0.976274220621224
714,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.848014390589839,0.976274220621224
715,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Up,0.849192296525761,0.976274220621224
716,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.851324842244237,0.977358966934026
717,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,21,Down,0.858416330025635,0.981690405653587
718,WP_EICOSANOID_SYNTHESIS,13,Down,0.860035922861711,0.981690405653587
719,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.863872185541151,0.981690405653587
720,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.864532282148786,0.981690405653587
721,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.864983127386263,0.981690405653587
722,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.865560471868281,0.981690405653587
723,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.865599684185189,0.981690405653587
724,WP_DRAVET_SYNDROME,13,Up,0.865601269440262,0.981690405653587
725,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.865846160704198,0.981690405653587
726,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.867603775618519,0.982328241816009
727,WP_FOXP3_IN_COVID19,10,Up,0.868960932581122,0.982385731499124
728,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.871839023572931,0.982385731499124
729,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.874929264953139,0.982385731499124
730,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,79,Down,0.875461988163395,0.982385731499124
731,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,21,Up,0.8768366069359,0.982385731499124
732,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,87,Down,0.876875537863176,0.982385731499124
733,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.877613915639408,0.982385731499124
734,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.877641964041546,0.982385731499124
735,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.87971175288456,0.982385731499124
736,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.882200984513014,0.982385731499124
737,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.884812826926737,0.982385731499124
738,WP_ATM_SIGNALING,34,Up,0.885128942498162,0.982385731499124
739,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.885503585955272,0.982385731499124
740,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.888363657239481,0.982385731499124
741,WP_OXIDATION_BY_CYTOCHROME_P450,15,Down,0.888794627893178,0.982385731499124
742,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.889099503994237,0.982385731499124
743,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.893090396288609,0.982385731499124
744,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.894701412966908,0.982385731499124
745,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.894882686632803,0.982385731499124
746,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,83,Down,0.895697832293494,0.982385731499124
747,WP_PPAR_SIGNALING,39,Down,0.896776932514652,0.982385731499124
748,WP_ONCOSTATIN_M_SIGNALING,56,Up,0.898077919452392,0.982385731499124
749,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,41,Up,0.899493151505503,0.982385731499124
750,WP_ENDODERM_DIFFERENTIATION,82,Up,0.901476142491174,0.982385731499124
751,WP_BLADDER_CANCER,29,Down,0.901524238122709,0.982385731499124
752,WP_ERBB_SIGNALING,67,Down,0.902331509649399,0.982385731499124
753,WP_SLEEP_REGULATION,11,Up,0.902341888088196,0.982385731499124
754,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.903436710795637,0.982385731499124
755,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Up,0.903528346147237,0.982385731499124
756,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.904256472255112,0.982385731499124
757,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.904703161490069,0.982385731499124
758,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,16,Up,0.908838850374423,0.985574584442976
759,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Down,0.910477722942842,0.986050972673275
760,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.914115682437324,0.988688277583527
761,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.916114307251866,0.98870693203144
762,WP_VALPROIC_ACID_PATHWAY,8,Up,0.916711697687698,0.98870693203144
763,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.917741349318721,0.98870693203144
764,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.919250270747477,0.989036286066002
765,WP_TCELL_ACTIVATION_SARSCOV2,61,Up,0.924371673244796,0.990961655349154
766,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,19,Down,0.927355515676116,0.990961655349154
767,WP_PREIMPLANTATION_EMBRYO,20,Up,0.931026800584259,0.990961655349154
768,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.931176182864076,0.990961655349154
769,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.931476577868322,0.990961655349154
770,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.931874675841824,0.990961655349154
771,WP_IL18_SIGNALING,193,Down,0.931936350510595,0.990961655349154
772,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.932752197508191,0.990961655349154
773,WP_MONOAMINE_TRANSPORT,12,Up,0.935491901861392,0.990961655349154
774,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.935590449501642,0.990961655349154
775,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.935739908764493,0.990961655349154
776,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Down,0.935909473449732,0.990961655349154
777,WP_13Q1212_COPY_NUMBER_VARIATION,21,Down,0.938439412807921,0.990961655349154
778,WP_RANKLRANK_SIGNALING,48,Up,0.938647353739919,0.990961655349154
779,WP_NRF2ARE_REGULATION,20,Up,0.939758081754627,0.990961655349154
780,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Up,0.941307201351276,0.990961655349154
781,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.942235128376218,0.990961655349154
782,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.944098317870703,0.990961655349154
783,WP_CILIOPATHIES,127,Up,0.946471279512388,0.990961655349154
784,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.946738903759266,0.990961655349154
785,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Down,0.947304416230688,0.990961655349154
786,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.947561874822914,0.990961655349154
787,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.950851527943884,0.993131267727641
788,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.953797792646629,0.993131267727641
789,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.954065393785236,0.993131267727641
790,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.954469223241894,0.993131267727641
791,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Up,0.95923951447398,0.996832972057663
792,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.961276829714624,0.997029661323995
793,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Down,0.961967595960282,0.997029661323995
794,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.963067580402983,0.997029661323995
795,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.964838280626152,0.99760637317572
796,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Up,0.968350298166539,0.997692942321809
797,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.969570824105993,0.997692942321809
798,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.969821122433939,0.997692942321809
799,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Up,0.97213282071944,0.997692942321809
800,WP_SELENIUM_MICRONUTRIENT_NETWORK,53,Down,0.97267137456748,0.997692942321809
801,WP_ACE_INHIBITOR_PATHWAY,3,Down,0.975493292903314,0.997692942321809
802,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.977010418240426,0.997692942321809
803,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.977441077558914,0.997692942321809
804,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.979336425401251,0.997692942321809
805,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.979530229385482,0.997692942321809
806,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.979778101615682,0.997692942321809
807,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.980528519798099,0.997692942321809
808,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,16,Down,0.982854730882471,0.997692942321809
809,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.984421573385359,0.997692942321809
810,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,16,Down,0.985933727772111,0.997692942321809
811,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.986160495166462,0.997692942321809
812,WP_AMINO_ACID_METABOLISM,59,Up,0.987264709713126,0.997692942321809
813,WP_TCELL_RECEPTOR_SIGNALING,73,Up,0.988460477511899,0.997692942321809
814,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Down,0.988536146102227,0.997692942321809
815,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.989389708784195,0.997692942321809
816,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.991619999231001,0.997692942321809
817,WP_ONECARBON_METABOLISM,22,Up,0.991868935460366,0.997692942321809
818,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,14,Up,0.993257294802726,0.997692942321809
819,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.994051727203846,0.997692942321809
820,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.995659254297323,0.998087691502927
821,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Up,0.998972192549211,0.999988262203913
822,WP_AUTOPHAGY,27,Up,0.999988262203913,0.999988262203913
